In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia.


CHS 828, a pyridyl cyanoguanidine, is a new drug candidate now in phase I/II trials, that has shown promising anticancer activity in experimental tumor models and primary cultures of cancer cells from patients. In this study the fluorometric microculture cytotoxicity assay was used for evaluation of CHS 828 in primary cell cultures from children with acute… (More)


  • Presentations referencing similar topics